Benitec Biopharma Ltd Stock Probability of Future Stock Price Finishing Over 6.0
| BNTC Stock | USD 10.24 0.51 5.24% |
Benitec |
Benitec Biopharma Target Price Odds to finish over 6.0
The tendency of Benitec Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 6.00 in 90 days |
| 10.24 | 90 days | 6.00 | close to 99 |
Based on a normal probability distribution, the odds of Benitec Biopharma to stay above $ 6.00 in 90 days from now is close to 99 (This Benitec Biopharma Ltd probability density function shows the probability of Benitec Stock to fall within a particular range of prices over 90 days) . Probability of Benitec Biopharma price to stay between $ 6.00 and its current price of $10.24 at the end of the 90-day period is about 67.94 .
Given the investment horizon of 90 days Benitec Biopharma has a beta of 0.18 suggesting as returns on the market go up, Benitec Biopharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Benitec Biopharma Ltd will be expected to be much smaller as well. Additionally Benitec Biopharma Ltd has an alpha of 0.1321, implying that it can generate a 0.13 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Benitec Biopharma Price Density |
| Price |
Predictive Modules for Benitec Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Benitec Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Benitec Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Benitec Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Benitec Biopharma is not an exception. The market had few large corrections towards the Benitec Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Benitec Biopharma Ltd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Benitec Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | 0.18 | |
σ | Overall volatility | 0.90 | |
Ir | Information ratio | 0.01 |
Benitec Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Benitec Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Benitec Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Benitec Biopharma had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 216 K. Net Loss for the year was (21.75 M) with profit before overhead, payroll, taxes, and interest of 75 K. | |
| Benitec Biopharma Ltd currently holds about 4.06 M in cash with (19.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5. | |
| Benitec Biopharma has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Benitec Biopharma to Participate in Upcoming Investor Conferences in December |
Benitec Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Benitec Stock often depends not only on the future outlook of the current and potential Benitec Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Benitec Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.1 M | |
| Cash And Short Term Investments | 50.9 M |
Benitec Biopharma Technical Analysis
Benitec Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Benitec Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Benitec Biopharma Ltd. In general, you should focus on analyzing Benitec Stock price patterns and their correlations with different microeconomic environments and drivers.
Benitec Biopharma Predictive Forecast Models
Benitec Biopharma's time-series forecasting models is one of many Benitec Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Benitec Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Benitec Biopharma
Checking the ongoing alerts about Benitec Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Benitec Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Benitec Biopharma had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 216 K. Net Loss for the year was (21.75 M) with profit before overhead, payroll, taxes, and interest of 75 K. | |
| Benitec Biopharma Ltd currently holds about 4.06 M in cash with (19.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5. | |
| Benitec Biopharma has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Benitec Biopharma to Participate in Upcoming Investor Conferences in December |
Check out Benitec Biopharma Backtesting, Benitec Biopharma Valuation, Benitec Biopharma Correlation, Benitec Biopharma Hype Analysis, Benitec Biopharma Volatility, Benitec Biopharma History as well as Benitec Biopharma Performance. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.51) | Revenue Per Share 0.003 | Quarterly Revenue Growth 0.125 | Return On Assets (0.50) | Return On Equity (0.92) |
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.